Allied BioTech’s research and development programs discover and patent wherever possible, platform technologies and methods to better identify and understand the principles of protein interaction.

Our vaccine research program incorporates the latest advances in immunology and infectious disease with industry knowledge and expertise in cGMP manufacturing to develop and deliver vaccines which are reliable and safe and that will make a difference to patients worldwide.

ABI has made a commitment to be a major player in the fast-growing field of proteomics and is leveraging its patented microarray technology with the brightest technical expertise available. Our protein microarray technology can be applied to Allergy Research, Animal Surveillance, Antibody / Serum Profiling, Biomarker Profiling, Cancer Research, Cytokine Detection, Infectious Disease Research, Protein – Protein Interactions, Signal Transduction and Whole Proteome Studies

The discovery and introduction of the technology known as Polymerase Chain Reaction (PCR) has made a quantum leap in the ability to detect the lowest levels of DNA and RNA in the laboratory. A single copy of a specific DNA sequence can now be amplified and detected in a short period of time. Real Time PCR offers the advantages of speed, accuracy and sensitivity over traditional assays.